Showing results (91-100 of 134) with videos related to
Sort By:
Pageof 14
European Journal of Immunology|January 1, 1996
Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor alpha, beta and gamma chain expression for T cell growthP Chastagner, J L Moreau, Y Jacques, et al.Blood|June 1, 1988
Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cellsA Godard, H Gascan, J Naulet, et al.The Journal of Clinical Investigation|October 1, 1986
T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysisJ F Moreau, M Bonneville, M A Peyrat, et al.The Journal of Biological Chemistry|June 20, 2000
Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinaseF Blanchard, L Duplomb, Y Wang, et al.Transplantation|March 1, 1989
Anti-interleukin 2 receptor monoclonal antibody in the treatment of ongoing acute rejection episodes of human kidney graft--a pilot studyD Cantarovich, B Le Mauff, M Hourmant, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 1992
Soluble interleukin 2 receptor (Tac chain) is not a reliable marker in kidney transplant recipient monitoringJ N Trochu, M Denis, J L Auget, et al.The New England Journal of Medicine|April 26, 1990
Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allograftsJ P Soulillou, D Cantarovich, B Le Mauff, et al.The Journal of Biological Chemistry|November 25, 1990
Biochemical study of a recombinant soluble interleukin-2 receptor. Evidence for a homodimeric structureY Jacques, B Le Mauff, A Godard, et al.FEBS Letters|June 1, 1999
A fusion protein of interleukin-11 and soluble interleukin-11 receptor acts as a superagonist on cells expressing gp130S Pflanz, I Tacken, J Grötzinger, et al.Transplantation|October 27, 1994
Rat interleukin-2 immunoglobulin M fusion proteins are cytotoxic in vitro for cells expressing the IL-2 receptor and can abolish cell-mediated immunity in vivoW M Bogers, F Lang, K E Parker, et al.Pageof 14